🇯🇵·Jan 1, 1970Industry
オプジーボ®点滴静注、根治切除不能な甲状腺未分化がんに対する効能または効果の追加に係る国内製造販売承認事項一部変更承認申請 | ONO CORPORATE
Publisher
O
Ono Pharmaceutical
Japan
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalAt a glance
- Publisher
- Ono Pharmaceutical
- Region
- Japan
- Scope
- Industry
- Published
- January 1, 1970
In-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Source route
Continue on ono-pharma.com
Leave the platform to read the original full article on the publisher site.
Source: Ono Pharmaceutical
Scope: Industry
Related coverage
More related coverage
Bristol-Myers Squibb News/5h ago
Bristol Myers Squibb to Report Results for Second Quarter 2026 on July 30, 2026
Merck & Co. (MSD) News/6h ago
U.S. FDA Approves an Additional Indication for CAPVAXIVE® (Pneumococcal 21-valent Conjugate Vaccine) in Children and Adolescents Aged 2 through 17 at Increased Risk for Pneumococcal Disease
Ipsen RSS/8h ago
Advancing Care in Renal Cell Carcinoma: Earlier Treatment, Better Outcomes, and Stronger Support for Patients
Roche Newsroom/11h ago